Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
March-2025 Volume 29 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2025 Volume 29 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.xlsx
    • Supplementary_Data2.xlsx
Article Open Access

LGALS4 inhibits glycolysis and promotes apoptosis of colorectal cancer cells via β‑catenin signaling

  • Authors:
    • Shengjie Li
    • Kaifeng Yang
    • Jiayou Ye
    • Chengfan Xu
    • Zhixiang Qin
    • Ying Chen
    • Lanjian Yu
    • Tianyu Zhou
    • Bin Sun
    • Jun Xu
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology Surgery, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443000, P.R. China, Center for Clinical Research and Translational Medicine, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200438, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 126
    |
    Published online on: January 7, 2025
       https://doi.org/10.3892/ol.2025.14873
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer‑related deaths worldwide. Glycolysis serves a crucial role in the development of CRC. The aim of the present study was to investigate the function of lectin galactoside‑binding soluble 4 (LGALS4) in the regulation of glycolysis and its therapeutic potential in CRC. In the present study, 175 overlapping differentially expressed genes were identified by comprehensive analysis of The Cancer Genome Atlas database and the GSE26571 CRC dataset from the Gene Expression Omnibus database. LGALS4 was identified as the central gene by prognostic analysis using the mimetic map construction method and least absolute shrinkage and selection operator Cox regression. In vitro experiments were performed to evaluate the effects of LGALS4 overexpression on CRC cell phenotype and aerobic glycolysis, as well as its relationship with β‑catenin signaling. LGALS4 was significantly downregulated in CRC, with an average 3‑fold decrease compared with LGALS4 expression levels in normal tissues. LGALS4 was also significantly associated with patient survival. LGALS4 overexpression inhibited CRC cell growth, induced cell cycle arrest and enhanced 5‑fluorouracil (5‑FU)‑induced apoptosis. Specifically, LGALS4 overexpression resulted in a ~50% decrease in cell proliferation and a ~2‑fold increase in apoptosis. In addition, LGALS4 overexpression inhibited aerobic glycolysis and reduced glucose‑dependent and glycolytic activity in CRC cells. The downregulatory effect of LGALS4 on glycolysis‑related genes was further enhanced by the addition of the β‑catenin inhibitor XAV‑939. LGALS4 expression decreased CRC progression by inhibiting glycolysis and affecting β‑catenin signaling. Overexpression of LGALS4 reduced the proliferation and glycolytic capacity of CRC cells and also enhanced their sensitivity to 5‑FU. These results may potentially provide new perspectives for CRC treatment and targets for future clinical intervention strategies.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Roshandel G, Ghasemi-Kebria F and Malekzadeh R: Colorectal cancer: Epidemiology, risk factors, and prevention. Cancers. 16:15302024. View Article : Google Scholar : PubMed/NCBI

2 

Parmar S and Easwaran H: Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Report. 10:goac0352022. View Article : Google Scholar : PubMed/NCBI

3 

Yu J, Feng Q, Kim JH and Zhu Y: Combined effect of healthy lifestyle factors and risks of colorectal adenoma, colorectal cancer, and colorectal cancer mortality: Systematic review and meta-analysis. Front Oncol. 12:8270192022. View Article : Google Scholar : PubMed/NCBI

4 

Wong MC, Huang J, Lok V, Wang J, Fung F, Ding H and Zheng ZJ: Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 19:955–966.e61. 2021. View Article : Google Scholar : PubMed/NCBI

5 

Biller LH and Schrag D: Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI

6 

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q and Xu H: Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target. Mol Cancer. 21:1442022. View Article : Google Scholar : PubMed/NCBI

7 

Satelli A, Rao PS, Thirumala S and Rao US: Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer. 129:799–809. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Michalak M, Golde V, Helm D, Kaltner H, Gebert J and Kopitz J: Combining Recombinase-mediated cassette exchange strategy with quantitative proteomic and Phosphoproteomic analyses to inspect intracellular functions of the tumor suppressor galectin-4 in colorectal cancer cells. Int J Mol Sci. 23:64142022. View Article : Google Scholar : PubMed/NCBI

9 

Zhang GL, Pan LL, Huang T and Wang JH: The transcriptome difference between colorectal tumor and normal tissues revealed by single-cell sequencing. J Cancer. 10:5883–5890. 2019. View Article : Google Scholar : PubMed/NCBI

10 

Cheraghi-Shavi T, Jalal R and Minuchehr Z: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. PLoS One. 18:e02895352023. View Article : Google Scholar : PubMed/NCBI

11 

Chandel NS: Glycolysis. Cold Spring Harb Perspect Biol. 13:a0405352021. View Article : Google Scholar : PubMed/NCBI

12 

Jaiswara PK, Gupta VK, Rawat SG, Tiwari RK, Sonker P, Maurya RP and Kumar A: Targeting of Aerobic Glycolysis: An Emerging Therapeutic Approach Against Colon Cancer. Colon Cancer Diagnosis and Therapy. Vol 2. Springer; pp. 225–244. 2021, View Article : Google Scholar

13 

Zuo S, Wu L, Wang Y and Yuan X: Long non-coding RNA MEG3 activated by vitamin D suppresses glycolysis in colorectal cancer via promoting c-Myc degradation. Front Oncol. 10:2742020. View Article : Google Scholar : PubMed/NCBI

14 

Zhu Y, Wu G, Yan W, Zhan H and Sun P: miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer. Am J Cancer Res. 7:11362017.PubMed/NCBI

15 

Zhu J, Wang S, Bai H, Wang K, Hao J, Zhang J and Li J: Identification of five glycolysis-related gene signature and risk score model for colorectal cancer. Front Oncol. 11:5888112021. View Article : Google Scholar : PubMed/NCBI

16 

Xiong Y, Lei J, Zhao J, Lu Q, Feng Y, Qiao T, Xin S, Han Y and Jiang T: A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis. BMC Cancer. 20:10462020. View Article : Google Scholar : PubMed/NCBI

17 

He R, Zhang M, He L, Huang J, Man C, Wang X, Lang Y and Fan Y: Integrated analysis of Necroptosis-related genes for prognosis, immune microenvironment infiltration, and drug sensitivity in colon cancer. Front Med (Lausanne). 9:8452712022. View Article : Google Scholar : PubMed/NCBI

18 

Hou S, Li L, Hou H, Zhou T and Zhou H: Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: A large population-based analysis. Discover Oncol. 15:3152024. View Article : Google Scholar : PubMed/NCBI

19 

Chen S, Su T, Zhang Y, Lee A, He J, Ge Q and Wang L, Si J, Zhuo W and Wang L: Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes. 11:511–525. 2020. View Article : Google Scholar : PubMed/NCBI

20 

Xu J, Xiao Y, Liu B, Pan S, Liu Q, Shan Y, Li S, Qi Y, Huang Y and Jia L: Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway. J Exp Clin Cancer Res. 39:542020. View Article : Google Scholar : PubMed/NCBI

21 

Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, Han S, Liu Y, Ying G, Shu X and Di M: TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 39:2322020. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Aslan M, Hsu EC, Liu S and Stoyanova T: Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assay. Biol Methods Protoc. 6:bpab0142021. View Article : Google Scholar : PubMed/NCBI

24 

Mao Z, Xiao H, Shen P, Yang Y, Xue J, Yang Y, Shang Y, Zhang L, Li X, Zhang Y, et al: KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge. Cell Discov. 8:52022. View Article : Google Scholar : PubMed/NCBI

25 

Chen H, Chen H, Zhang J, Wang Y, Simoneau A, Yang H, Levine AS, Zou L, Chen Z and Lan L: cGAS suppresses genomic instability as a decelerator of replication forks. Sci Adv. 6:eabb89412020. View Article : Google Scholar : PubMed/NCBI

26 

Liu Y, Zhang X, Wang W, Liu T, Ren J, Chen S, Lu T, Tie Y, Yuan X, Mo F, et al: Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway. Bone Res. 10:572022. View Article : Google Scholar : PubMed/NCBI

27 

Acharjee A, Agarwal P, Nash K, Bano S, Rahman T and Gkoutos GV: Immune infiltration and prognostic and diagnostic use of LGALS4 in colon adenocarcinoma and bladder urothelial carcinoma. Am J Transl Res. 13:113532021.PubMed/NCBI

28 

Principe M, Borgoni S, Cascione M, Chattaragada MS, Ferri-Borgogno S, Capello M, Bulfamante S, Chapelle J, Di Modugno F, Defilippi P, et al: Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol. 10:162017. View Article : Google Scholar : PubMed/NCBI

29 

Ding L, Cao J, Lin W, Chen H, Xiong X, Ao H, Yu M, Lin J and Cui Q: The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci. 21:19602020. View Article : Google Scholar : PubMed/NCBI

30 

Sun L, Suo C, Li ST, Zhang H and Gao P: Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect. Biochim Biophys Acta Rev Cancer. 1870:51–66. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, Deng HJ, Pan SM, Wu DH and Ding Y: CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 10:39812019. View Article : Google Scholar : PubMed/NCBI

32 

Zhang M, Song H, Yang S, Zhang Y, Tian Y, Wang Y and Liu D: Deciphering the antibacterial mechanisms of 5-fluorouracil in Escherichia coli through biochemical and transcriptomic analyses. Antibiotics. 13:5282024. View Article : Google Scholar : PubMed/NCBI

33 

Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S and Al Moustafa AE: Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int J Mol Sci. 22:1302020. View Article : Google Scholar : PubMed/NCBI

34 

Zou Y, Liu FY, Liu H, Wang F, Li W, Huang MZ, Huang Y, Yuan XQ, Xu XY, Huang OP and He M: Frequent POLE1 p. S297F mutation in Chinese patients with ovarian endometrioid carcinoma. Mutat Res. 761:49–52. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Zurlo D, Leone C, Assante G, Salzano S, Renzone G, Scaloni A, Foresta C, Colantuoni V and Lupo A: Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21waf1/cip1 expression in human colon carcinoma HT-29 cells. Mol Carcinog. 52:1–17. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Patil R, Sontakke T, Biradar A and Nalage D: Zinc: An essential trace element for human health and beyond. Food Health. 5:132023. View Article : Google Scholar

37 

Haase H and Rink L: Zinc signals and immune function. Biofactors. 40:27–40. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Pelletier J, Thomas G and Volarević S: Ribosome biogenesis in cancer: New players and therapeutic avenues. Nat Rev Cancer. 18:51–63. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Villalobo A: Ca2+ signaling and Src functions in tumor cells. Biomolecules. 13:17392023. View Article : Google Scholar : PubMed/NCBI

40 

Zurlo D, Assante G, Moricca S, Colantuoni V and Lupo A: Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation. Biochim Biophys Acta. 1840:2361–2372. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Yu C, Hong H, Zhang S, Zong Y, Ma J, Lu A, Sun J and Zheng M: Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. Mol Med Rep. 19:2065–2076. 2019.PubMed/NCBI

42 

Günther J and Galuska SP: A brief history of galectin evolution. Front Immunol. 14:11473562023. View Article : Google Scholar : PubMed/NCBI

43 

Ferlizza E, Solmi R, Miglio R, Nardi E, Mattei G, Sgarzi M and Lauriola M: Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects. J Adv Res. 24:99–107. 2020. View Article : Google Scholar : PubMed/NCBI

44 

Watanabe M, Takemasa I, Kaneko N, Yokoyama Y, Matsuo EI, Iwasa S, Mori M, Matsuura N, Monden M and Nishimura O: Clinical significance of circulating galectins as colorectal cancer markers. Oncol Rep. 25:1217–1226. 2011.PubMed/NCBI

45 

Zhou J, Belov L, Chapuis P, Chan C, Armstrong N, Kaufman KL, Solomon MJ, Clarke SJ and Christopherson RI: Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories. J Immunol Methods. 416:59–68. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Passarella S, Schurr A and Portincasa P: Mitochondrial transport in glycolysis and gluconeogenesis: Achievements and perspectives. Int J Mol Sci. 22:126202021. View Article : Google Scholar : PubMed/NCBI

47 

Gupta R and Gupta N, Gupta R and Gupta N: Glycolysis and gluconeogenesis. Fundamentals of bacterial physiology and metabolism. 267–287. 2021. View Article : Google Scholar

48 

Zhou L, Yu X, Li M, Gong G, Liu W, Li T, Zuo H, Li W, Gao F and Liu H: Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth. EBioMedicine. 51:1025702020. View Article : Google Scholar : PubMed/NCBI

49 

Zhou CF, Li XB, Sun H, Zhang B, Han YS, Jiang Y, Zhuang QL, Fang J and Wu GH: Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. IUBMB Life. 64:775–782. 2012. View Article : Google Scholar : PubMed/NCBI

50 

Zhao J, Li J, Hassan W, Xu D, Wang X and Huang Z: Sam68 promotes aerobic glycolysis in colorectal cancer by regulating PKM2 alternative splicing. Ann Transl Med. 8:4592020. View Article : Google Scholar : PubMed/NCBI

51 

Sethy C and Kundu CN: 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 137:1112852021. View Article : Google Scholar : PubMed/NCBI

52 

Zou X, Liang J, Sun J, Hu X, Lei L, Wu D and Liu L: Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. J Pharmacol Sci. 131:233–240. 2016. View Article : Google Scholar : PubMed/NCBI

53 

Zou K, JU JH and Xie H: Pretreatment with insulin enhances anticancer functions of 5-fluorou-racil in human esophageal and colonic cancer cells. Acta Pharmacol Sin. 28:721–730. 2007. View Article : Google Scholar : PubMed/NCBI

54 

Zuo T, Zhang Z, Jiang P, Zhang R, Ni D, Yuan Y and Zhang S: Characterization of chikusetsusaponin IV and V induced apoptosis in HepG2 cancer cells. Mol Biol Rep. 49:4247–4255. 2022. View Article : Google Scholar : PubMed/NCBI

55 

Raeisi E and Mir LM: 2-NBDG, a fluorescent analogue of glucose, as a marker for detecting cell electropermeabilization in vitro. J Membr Biol. 245:633–642. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Lin HC, Chen YJ, Wei YH, Lin HA, Chen CC, Liu TF, Hsieh YL, Huang KY, Lin KH, Wang HH and Chen LC: Lactic acid fermentation is required for NLRP3 inflammasome activation. Front Immunol. 12:6303802021. View Article : Google Scholar : PubMed/NCBI

57 

Akram M: Mini-review on glycolysis and cancer. J Cancer Educ. 28:454–457. 2013. View Article : Google Scholar : PubMed/NCBI

58 

Mondal P, Tiwary N, Sengupta A, Dhang S, Roy S and Das C: Epigenetic reprogramming of the glucose metabolic pathways by the chromatin effectors during cancer. Subcell Biochem. 100:269–336. 2022. View Article : Google Scholar : PubMed/NCBI

59 

Zhou Q, Li J, Pang J, Fan F, Li S and Liu H: Gefitinib inhibits glycolysis and induces programmed cell death in non-small cell lung cancer cells. Nan Fang Yi Ke Da Xue Xue Bao. 40:884–892. 2020.(In Chinese). PubMed/NCBI

60 

Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH and Pizzorno G: ATP citrate lyase inhibitors as novel cancer therapeutic agents. Recent Pat Anticancer Drug Discov. 7:154–167. 2012. View Article : Google Scholar : PubMed/NCBI

61 

Zuo Xm, Sun Hw, Fang H, Wu Y, Shi Q and Yu YF: miR-4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro. Cell Biol Int. 45:1917–1925. 2021. View Article : Google Scholar : PubMed/NCBI

62 

Shah K and Kazi JU: Phosphorylation-dependent regulation of WNT/Beta-catenin signaling. Front Oncol. 12:8587822022. View Article : Google Scholar : PubMed/NCBI

63 

Jung YS and Park JI: Wnt signaling in cancer: Therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med. 52:183–191. 2020. View Article : Google Scholar : PubMed/NCBI

64 

van Zuylen WJ, Rawlinson WD and Ford CE: The Wnt pathway: A key network in cell signalling dysregulated by viruses. Rev Med Virol. 26:340–355. 2016. View Article : Google Scholar : PubMed/NCBI

65 

Zou Y, Liu L, Meng J and Dai M: Circular RNA circ_0068464 combined with microRNA-383 regulates Wnt/β-catenin pathway to promote the progression of colorectal cancer. Bioengineered. 13:5113–5125. 2022. View Article : Google Scholar : PubMed/NCBI

66 

Zou J, Huang Y, Chen Y, Wu Z, Xie H, Zhou H and Xing C: FOXC2-induced circCASK aggravates colorectal cancer progression by upregulating SIX1 expression. IUBMB Life. 75:659–672. 2023. View Article : Google Scholar : PubMed/NCBI

67 

Zhou Y, Gu H, Shao B, Zhang S, Pall H, Peixoto RD, Mok SRS and Zhu G: Glycolysis-related gene dihydrolipoamide acetyltransferase promotes poor prognosis in hepatocellular carcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways. Ann Transl Med. 10:12402022. View Article : Google Scholar : PubMed/NCBI

68 

Zhou J, Su CM, Chen HA, Du S, Li CW, Wu H, Tsai SH and Yeh YT: Cryptanshinone inhibits the glycolysis and inhibits cell migration through PKM2/β-catenin axis in breast cancer. Onco Targets Ther. 13:8629–8639. 2020. View Article : Google Scholar : PubMed/NCBI

69 

Wenxuan L, Liu L, Zhang L, Qiu Z, Wu Z and Deng W: Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment. Front Oncol. 13:13238262023. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li S, Yang K, Ye J, Xu C, Qin Z, Chen Y, Yu L, Zhou T, Sun B, Xu J, Xu J, et al: <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncol Lett 29: 126, 2025.
APA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y. ... Xu, J. (2025). <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncology Letters, 29, 126. https://doi.org/10.3892/ol.2025.14873
MLA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29.3 (2025): 126.
Chicago
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29, no. 3 (2025): 126. https://doi.org/10.3892/ol.2025.14873
Copy and paste a formatted citation
x
Spandidos Publications style
Li S, Yang K, Ye J, Xu C, Qin Z, Chen Y, Yu L, Zhou T, Sun B, Xu J, Xu J, et al: <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncol Lett 29: 126, 2025.
APA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y. ... Xu, J. (2025). <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncology Letters, 29, 126. https://doi.org/10.3892/ol.2025.14873
MLA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29.3 (2025): 126.
Chicago
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29, no. 3 (2025): 126. https://doi.org/10.3892/ol.2025.14873
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team